On Demand 2026 Monday General Sessions
This course contains the following sessions from Monday's program:
- Plenary: The Food Allergy GRADE Practice Parameter
- New Horizons for Angioedema: From First Presentation to Long-Term Control
- Staying on the Cutting Edge of Drug Allergy Diagnostics
- The Difficult to Control Asthma Practice Parameter - Cutting Edge Care for Practice
- Precision Immunology: Practical Tools for the Diagnosis and Management of Monogenic Disorders of Immunity
- The Power of Your Voice: Practical Advocacy for the Next Generation of Allergists
Accreditation
The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this enduring material for a maximum of 7.75 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Target Audience
Medical professionals who treat patients with allergic and/or immunological conditions:
- Practicing allergist/immunologists
- Allergy/immunology Fellows-in-Training
- Physician assistants
- Nurses and advanced practice nurses
- Allied health professionals
- Primary care physicians
- Other medical professionals
Learning Objectives
Upon completion of this session, participants should be able to:
- Describe key evidence-based recommendations from the updated Food Allergy Practice Parameter regarding the risk factors for development of IgE mediated food allergy.
- Interpret the GRADE methodology used in developing the Food Allergy Practice Parameter and incorporate its evidence-based recommendations into standardizing oral food challenge and determining individual threshold for food allergy reactions.
- Apply guideline-based recommendations for the management of eosinophilic esophagitis, and where current management options fall in the paradigm of treatment.
- Identify clinical features that distinguish histaminergic angioedema vs. bradykinin-mediated angioedema. Outline the appropriate diagnostic evaluation for angioedema, including HAE with normal C1 inhibitor.
- Describe the epidemiology of HAE with normal C1 inhibitor and appropriate management strategies.
- Compare current HAE abortive and prophylaxis options and emerging therapies and their mechanisms of action.
- Gain knowledge on recent RCTs in drug allergy evaluations.
- Assess new information from the Optimizing the Diagnostic Approach to Cephalosporin Allergy Testing (DACAT) trial.
- Recognize current tools available for diagnostic testing and risk stratification including tools in the ACAAI Penicillin Toolkit and drug allergy toolbox.
- Recognize the importance of resources used to construct the updated parameter.
- Review key recommendations regarding anti-inflammatory relievers and biologics.
- Evaluate and select appropriate practice parameters to manage severe or difficult to treat asthma.
- Analyze immunologic and non-immunologic features frequently seen in patients with monogenic disorders of immunity and how a genetic diagnosis can lead to precision therapies.
- Recognize the basics of genetic sequence nomenclature and develop a framework for evaluating variants of uncertain significance that are frequently encountered when ordering genetic testing.
- Identify new and emerging diagnostic tests that can help guide treatment in patients with features of immune deficiency and/or dysregulation.
- Analyze how federal healthcare policies influence allergy and immunology practice and identify opportunities to participate in national-level advocacy efforts.
- Evaluate local healthcare policies that affect allergy care and implement strategies to monitor and address policy issues within one’s own community.
- Develop effective collaborations with patient advocacy organizations to enhance community education, support patient needs, and strengthen allergy and immunology care delivery. Apply evidence-based communication strategies to create impactful social media messaging that supports patient education and counters
Course summary
- 7.75 AMA PRA Category 1 Credit™
- 7.75 Attendance
- 7.75 CBRN
Kristin C. Sokol, MD, MS, MPH, FACAAI
Derek K. Chu, MD, PhD
Aikaterini Anagnostou, MD, MSc, PhD, FACAAI
Jay A. Lieberman, MD, FACAAI
Alissa B McInerney, MD, FACAAI
Aleena Banerji, MD, FACAAI
Karen S. Hsu Blatman, MD, FACAAI
Marc A. Riedl, MD, MS
David A. Khan, MD, FACAAI
David C. Mari, DO
Aiwei Yan, MD
Allison C. Ramsey, MD, FACAAI
Kimberly G. Blumenthal, MD, MSc, FACAAI
Cosby A. Stone, Jr., MD, MPH
Sharmilee M. Nyenhuis, MD
Matthew A. Rank, MD, FACAAI
Leonard B. Bacharier, MD, FACAAI
Niraj Patel, MD, MS
Jonathan S. Tam, MD, FACAAI
Nikita Raje, MD, FACAAI
Ivan Chinn, MD
Roshini S. Abraham, PhD
Marissa A. Love, MD, FACAAI
Kylie N. Jungles, MD
Travis A. Miller, MD, FACAAI
Lynda G Mitchell, MA, CAE
Farah N. Khan, MD, FACAAI, FAAAAI, FAAP
Available Credit
- 7.75 AMA PRA Category 1 Credit™
- 7.75 Attendance
- 7.75 CBRN

Facebook
X
LinkedIn
Forward